2021 American Transplant Congress

June 4-9, 2021

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

View by Title View Sessions View Topics

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Comparison of Allograft Outcomes in SLK Transplant Patients with and without ESLD: A UNOS Database Analysis

P. Kyriazis, H. Patel, P. Nissaisorakarn, F. Cardarelli, N. Agrawal
Comparison of Donor-derived Cell Free Dna Between Recipients with First Solitary Allograft and Regrafts

S. Paluri¹, S. Muthusamy¹, M. Shinbashi¹, G. Gupta¹, B. Dale², Z. Kashi³, P. Halloran⁴, D. Kumar¹
Comparison of Kidney Transplantation Outcomes Between Donors After Controlled Circulatory Death and Brain Death Donors in Catalonia, Spain

J. Juega¹, M. Pérez-Sáez², J. Comas³, A. Zapatero⁴, M. Crespo², J. Tort³, R. Lauzurica¹, J. Pascual²
Comparison of Next Generation Sequencing Donor-derived Cell Free DNA Assay Utilizing Whole Genome Sequencing

N. Singh¹, M. S. Naseer¹, D. Aultman², H. Shokouh-Amiri², G. Zibari²
Comparison of Outcomes in Sot Recipients During Two Eras of Covid-19 Therapeutics

T. Chiang, A. Sait, A. Massie, K. Marr, D. Brennan, W. Cochran, P. Shah, T. Jain, S. Mehta Steinke, N. Desai, N. Permpalung, S. Shoham, C. Merlo, C. Durand, W. Werbel, M. Dioverti, D. Ostrander, A. Gurakar, M. Y. Kim, J. Garonzik-Wang, D. Segev, R. Avery
Comparison of Outcomes of Hepatitis C Virus (hcv) Nucleic Acid (nat) Positive Donor Between Hcv-naïVe and Hcv + Recpients – A Donor Mate Analysis

J. Kamal, B. Sharma, A. Doyle, A. Kumar, A. Nishio-Lucar, S. Rao
Comparison of Outcomes of Living Donor Liver Transplantation for Biliary Atresia Patients with and without Kasai Portoenterostomy

T. Kanmaz¹, O. Andacoglu¹, Y. Yankol², C. Karatas¹, N. Mecit¹, K. Acarli³, M. Kalayoglu¹
Compatible Paired Donation in Paired Kidney Exchange: A Look at the Road Not Taken

G. Vranic, A. Gilbert, B. Thomas, S. Ghasemian, M. Cooper, J. Verbesey
Complement Blockade Improves Renal Xenograft Survival in Primates in the Absence of Transgenic Complement Regulatory Proteins

D. A. Faber¹, B. Lovasik¹, A. Matar¹, C. Breeden¹, A. B. Farris², M. Tector³, A. Tector³, A. Adams⁴
Composition of Ex Vivo Lung Perfusion Solutions and Kinetics Define Differential Cytokine and Chemokine Secretion in a Porcine Cardiac Arrest Model of Lung Preservation

L. M. Radomsky¹, A. Koch², C. Olbertz², J. F. Kuehne¹, Y. Liu², J. Keil¹, K. Beushausen¹, U. Rauen³, C. S. Falk¹, M. Kamler²

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z